Butterfly Network, Inc., a digital health company, develops, manufactures, and markets ultrasound imaging solutions in the United States and internationally. The company is headquartered in Guilford, Connecticut.
| Revenue (TTM) | $102.92M |
| Gross Profit (TTM) | $68.04M |
| EBITDA | $-50.43M |
| Operating Margin | -50.80% |
| Return on Equity | -35.20% |
| Return on Assets | -11.20% |
| Revenue/Share (TTM) | $0.41 |
| Book Value | $0.73 |
| Price-to-Book | 9.67 |
| Price-to-Sales (TTM) | 18.23 |
| EV/Revenue | 16.83 |
| EV/EBITDA | -9.57 |
| Quarterly Earnings Growth (YoY) | 0.00% |
| Quarterly Revenue Growth (YoY) | 25.00% |
| Shares Outstanding | $235.21M |
| Float | $193.21M |
| % Insiders | 10.84% |
| % Institutions | 55.32% |
Volatility is currently expanding
Butterfly Network's second-quarter results may hinge on rising iQ3 demand, Compass AI adoption and Embedded growth, as revenues are expected to climb 21.5%.
BFLY launches Butterfly iQ+ and iQ3 in Brazil, expanding its handheld ultrasound reach into a major Latin American medical device market.
Butterfly Network's partner Aleph Neuro showcases non-invasive 3D brain imaging, highlighting the reach of its Ultrasound-on-Chip platform.
BURLINGTON, Mass.--(BUSINESS WIRE)---- $BFLY #POCUS--Butterfly Network, Inc. (“Butterfly”) (NYSE: BFLY), a pioneer and leader in semiconductor-based ultrasound devices, programmable cloud software and AI, today announced the commercial availability of its Butterfly iQ+ and iQ3 handheld ultrasound devices and mobile application in Brazil through a network of authorized distribution partners. Brazil is the largest medical device market in Latin America and one of the fastest-growing ultrasound markets globally,1,.
Each week, Benzinga's Stock Whisper Index uses a combination of proprietary data and pattern recognition to showcase five stocks that are just under the surface and deserve attention.
Here is how Butterfly Network, Inc. (BFLY) and American Well Corporation (AMWL) have performed compared to their sector so far this year.
BURLINGTON, Mass. & NEW YORK--(BUSINESS WIRE)---- $BFLY #BCI--Butterfly Network, Inc. ("Butterfly") (NYSE: BFLY), a pioneer and leader in semiconductor-based ultrasound devices, programmable cloud software and AI, today responded to Aleph Neuro (Aleph)'s public launch and announcement of what it describes as a breakthrough in non-invasive brain imaging using ultrasound. Aleph is a participant in the Butterfly Embedded™ licensing and co-development program powering a new wave of ultrasound-enabled technologies.
Monday's trading session shows signs of weakness, though @Stockstotrade's Tim Bohen sees Wall Street staying resilient and points out opportunities he likes in several corners of the stock market. He sees Intel (INTC) continuing bullish momentum, Citigroup (C) holding its upside trend into earnings, and Butterfly Network (BFLY) as a volatile opportunity following its Midjourney collaboration.
Butterfly Network is transforming from an ultrasound device maker to a semiconductor-driven healthcare technology platform. BFLY's silicon-based transducer technology enables multi-application flexibility and positions the company for licensing and ecosystem growth. Recent partnerships, including Midjourney, validate BFLY's platform strategy and open significant long-term licensing and royalty opportunities.
Butterfly Network (BFLY) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock doesn't suggest further strength down the road.
Tiblio connects your broker and runs your put-and-call-writing strategy for you — on BFLY and any ticker you trade — then tracks every position and per-strategy win rate.
